Kövesi G, Fekete B
Haematologia (Budap). 1985;18(1):27-32.
Fourty-five patients with head and neck cancer and 30 healthy subjects were evaluated by a modified humoral leukocyte adherence inhibition assay using basic encephalitogenic protein as antigen. Ninety-three percent of cancer patients gave a positive reaction, whereas every control person remained negative. The results suggest that humoral leukocyte adherence inhibition assay performed with basic encephalitogenic protein may be useful as an early diagnostic tool in head and neck cancer.
使用碱性致脑炎蛋白作为抗原，通过改良的体液白细胞黏附抑制试验对45例头颈癌患者和30名健康受试者进行了评估。93%的癌症患者呈阳性反应，而所有对照者均为阴性。结果表明，用碱性致脑炎蛋白进行的体液白细胞黏附抑制试验可能作为头颈癌的一种早期诊断工具。
